Results about: peptide synthesis
International patient advocates partner to fund Spanish gene-therapy project to treat Friedreich's ataxia
Scientists at the Institute for Research in Biomedicine (IRB) and the “Centro de Biología Molecular Severo Ochoa” (CBMSO) launched the project two months ago.
The project is the result of an initiative of Spanish people affected by this rare disease who are grouped in GENEFA in collaboration with the Spanish Federation of Ataxias and the BabelFAmily. The Friedreich’s Ataxia Research Alliance (FARA), one of the main patients’ associations in the United States now joins the endeavour.
The support provided by FARA will account for 50% of the project budget of 300,000 euros. Of note, FARA’s funds come from the support of patient families and communities raising funds at a grassroots level and from other International advocates such as FARA – Ireland.
Chemists at IRB Barcelona synthesize baringolin, a substance isolated from the depths of the sea by the pharmaceutical company BioMar S.A. At very small doses this compound inhibits the growth of antibiotic-resistant bacteria.
The congress “Chemistry for Life Sciences”, being held in Barcelona, is hosting more than 200 international chemists, who answer questions and offer solutions to biomedical problems.
The European congress has been organised by IRB Barcelona researchers headed by Ernest Giralt, coordinator of the Chemistry and Molecular Pharmacology Programme.